Organicell Regenerative Medicine : ANNOUNCES MATT SINNREICH AS CEO - Form 8-K
Organicell Regenerative Medicine, Inc. , a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics in the extracellular vesicle space,...
Source: marketscreener.com